UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

The Bank of England risks inflicting unnecessary damage to the economy by keeping interest rates too high for too long, a ...

Bakerhouse Rd in Nelson is currently closed whilst repairs are carried out and these could take up to four hours. Police are ...

A Stocks and Shares ISA is a Foolish favourite as investment vehicles go. Our writer details two picks she’d buy for hers to ...

A road has been closed as repairs take place to railway barriers. Bakerhouse Rd in Nelson is currently closed whilst repairs are carried out and these could take up to four hours. Police are advising ...

(Reuters) - GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court ...

GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion.